142 related articles for article (PubMed ID: 16306151)
21. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
22. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
Feoktistov I; Goldstein AE; Biaggioni I
Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells.
Turner NA; Xia F; Azhar G; Zhang X; Liu L; Wei JY
J Mol Cell Cardiol; 1998 Sep; 30(9):1789-801. PubMed ID: 9769235
[TBL] [Abstract][Full Text] [Related]
24. Comparison of JNK (c-Jun N-terminal kinase)-like MAPK (mitogen-activated protein kinase) phosphorylation between immobilized cultures and Couette-type shear reactor cultures of Taxus cuspidata (Japanese yew) cells.
Cheng JS; Yuan YJ
Biotechnol Appl Biochem; 2006 May; 44(Pt 2):109-17. PubMed ID: 16475978
[TBL] [Abstract][Full Text] [Related]
25. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
Chen KC; Liu WH; Chang LS
J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
[TBL] [Abstract][Full Text] [Related]
26. Role of JNK and p38 MAPK in Taiwanin A-induced cell death.
Ho PJ; Chou CK; Yeh SF
Life Sci; 2012 Dec; 91(25-26):1358-65. PubMed ID: 23123629
[TBL] [Abstract][Full Text] [Related]
27. Role of mitogen activated protein kinases in skin tumorigenicity of patulin.
Saxena N; Ansari KM; Kumar R; Chaudhari BP; Dwivedi PD; Das M
Toxicol Appl Pharmacol; 2011 Dec; 257(2):264-71. PubMed ID: 21964610
[TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
29. Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy.
Tai TY; Warner LN; Jones TD; Jung S; Concepcion FA; Skyrud DW; Fender J; Liu Y; Williams AD; Neumaier JF; D'Ambrosio R; Poolos NP
Neuroscience; 2017 May; 349():35-47. PubMed ID: 28237815
[TBL] [Abstract][Full Text] [Related]
30. Pro-life role for c-Jun N-terminal kinase and p38 mitogen-activated protein kinase at rostral ventrolateral medulla in experimental brain stem death.
Chang AY
J Biomed Sci; 2012 Nov; 19(1):96. PubMed ID: 23157661
[TBL] [Abstract][Full Text] [Related]
31. Dynamic modeling and simulation of JNK and P38 kinase cascades with feedbacks and crosstalks.
Sundaramurthy P; Gakkhar S
IEEE Trans Nanobioscience; 2010 Dec; 9(4):225-31. PubMed ID: 20729175
[TBL] [Abstract][Full Text] [Related]
32. Puerarin reduces apoptosis in rat hippocampal neurons culturea in high glucose medium by modulating the p38 mitogen activated protein kinase and c-Jun N-terminal kinase signaling pathways.
Xu X; Wang J; Zhang H; Tian G; Liu Y
J Tradit Chin Med; 2016 Feb; 36(1):78-84. PubMed ID: 26946623
[TBL] [Abstract][Full Text] [Related]
33. Patulin-induced genotoxicity and modulation of glutathione in HepG2 cells.
Zhou SM; Jiang LP; Geng CY; Cao J; Zhong LF
Toxicon; 2009 Apr; 53(5):584-6. PubMed ID: 19673104
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of Sec8 enhances the binding affinity of c-Jun N-terminal kinase (JNK)-interacting protein 4 for mitogen-activated protein kinase kinase 4 (MKK4) and suppresses the phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis.
Tanaka T; Iino M; Goto K
FEBS J; 2014 Dec; 281(23):5237-50. PubMed ID: 25244576
[TBL] [Abstract][Full Text] [Related]
35. Identification of caspase-independent PKCepsilon-JNK/p38 MAPK signaling module in response to metabolic inhibition in H9c2 cells.
Jung YS; Jung YS; Kim MY; Kim E
Jpn J Physiol; 2004 Feb; 54(1):23-9. PubMed ID: 15040845
[TBL] [Abstract][Full Text] [Related]
36. GADD45a Regulates Olaquindox-Induced DNA Damage and S-Phase Arrest in Human Hepatoma G2 Cells via JNK/p38 Pathways.
Li D; Dai C; Yang X; Li B; Xiao X; Tang S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098804
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis and activation of JNK and p38 MAPK pathways in deoxynivalenol-treated cell lines.
Baltriukiene D; Kalvelyte A; Bukelskiene V
Altern Lab Anim; 2007 Mar; 35(1):53-9. PubMed ID: 17411352
[TBL] [Abstract][Full Text] [Related]
38. Cellular iron depletion stimulates the JNK and p38 MAPK signaling transduction pathways, dissociation of ASK1-thioredoxin, and activation of ASK1.
Yu Y; Richardson DR
J Biol Chem; 2011 Apr; 286(17):15413-27. PubMed ID: 21378396
[TBL] [Abstract][Full Text] [Related]
39. TGF-β/Smad signaling pathway plays a crucial role in patulin-induced pro-fibrotic changes in rat kidney via modulation of slug and snail expression.
Pal S; Singh N; Dev I; Sharma V; Jagdale PR; Ayanur A; Ansari KM
Toxicol Appl Pharmacol; 2022 Jan; 434():115819. PubMed ID: 34896196
[TBL] [Abstract][Full Text] [Related]
40. Patulin-induced oxidative DNA damage and p53 modulation in HepG2 cells.
Zhou SM; Jiang LP; Geng CY; Cao J; Zhong LF
Toxicon; 2010; 55(2-3):390-5. PubMed ID: 19744505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
